- LIVE QUOTES
- LEARN
- HELP
More from Webull
Our Partners
Nasdaq
Wall Street JournalEN
E
EMBC
Embecta Corp
11.69
0.16+1.39%After Hours: 11.69 0.00 0.00%17:52 12/05 EST
OPEN/PREV CLOSE11.53/11.53
TODAY RANGE11.50-11.89
VOL972.21K
MARKET CAP684.02M
52 WEEK RANGE8.99-20.32
AVG VOL (3M)485.50K
% TURNOVER1.66%
TURNOVER--
P/E (TTM)7.22
% RANGE3.38%
EPS(TTM)1.619
P/E(FORWARD)4.811
P/B-1.0511
BVPS-11.1221
DIVIDEND0.6000
P/S0.6329
BETA--
DIV YIELD5.13%
FREE FLOAT MKT CAP673.58M
SHARES OUTSTANDING58.51M
NEXT EARNINGS02/04-02/09
FREE FLOAT57.62M
LOT SIZE1
EX-DATE12/05/2025
News
Press Releases
Financial Reports
Profile
Seeking Alpha·11/29 14:30
Embecta Growth Stalls Despite Strong Fiscal 2025 Results (Rating Downgrade)
Simply Wall St·11/28 10:43
US$16.67: That's What Analysts Think Embecta Corp. (NASDAQ:EMBC) Is Worth After Its Latest Results
Simply Wall St·11/27 07:26
Embecta (EMBC) Net Profit Margin Rises to 8.8%, Challenging Bearish Margin Narratives
Seeking Alpha·11/26 15:37
Meet 33 Ideal "Safer" November Small/MidCap Value DiviBuys Of The S&P600
TipRanks·11/26 04:02
Embecta Corporation Reports Mixed Fiscal 2025 Results
TipRanks·11/26 00:10
Embecta Corp. Earnings Call: Strategic Wins Amid Revenue Challenges
Seeking Alpha·11/25 16:24
Embecta outlines $100M GLP-1 revenue opportunity by 2033 as company advances global brand transition
Seeking Alpha·11/25 13:08
Embecta declares $0.15 dividend
Reuters·11/25 11:43
Insulin syringe maker Embecta's Q4 revenue just misses estimates
NASDAQ·11/25 11:43
Embecta Corp. Q4 Profit Increases, Beats Estimates
TipRanks·11/25 11:35
Embecta reports Q4 adjusted EPS 50c, consensus 46c
Seeking Alpha·11/25 11:33
Embecta gives mixed Q4 numbers, gives 2026 guidance
Dow Jones·11/25 11:33
*Embecta Sees FY26 Adj EPS $2.80-Adj EPS $3 >EMBC
Dow Jones·11/25 11:33
*Embecta Sees FY26 Rev $1.07B-$1.09B >EMBC
Same Industry
Name/Symbol
Change%
Price